Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma

International Journal of Andrology

Volumn 32, Issue 6, 2009, Pages 607-615

  Mendoza, Patricia ^a   Sánchez, Catherine ^a   Contreras, Héctor R ^a   Vergara, Jorge ^a   Acevedo, Cristian ^b   Cabezas, Juan ^b   Huidobro, Christian ^b   Noé, Gabriela ^c   Castellón, Enrique A ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c Chilean Institute for Reproductive Medicine   (Chile)

Author keywords

7 alpha methyl 19 nortestosterone; Androgens; Benign prostatic hyperplasia; Cell culture; Prostate cancer

Indexed keywords

ANDROSTANOLONE; FIBROBLAST GROWTH FACTOR 8; FINASTERIDE; KI 67 ANTIGEN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TRESTOLONE;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCHEMISTRY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY;

ANDROGENS; DIHYDROTESTOSTERONE; FINASTERIDE; HUMANS; MALE; NANDROLONE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTOSTERONE; TESTOSTERONE CONGENERS;

EID: 70449366485     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2008.00906.x     Document Type: Article

References (34)

1. Agarwal, A. K. Monder, C. (1988) In vitro metabolism of 7-alpha-methyl-19-nortestosterone by rat liver, prostate and epididymis. Endocrinology 123, 2187 2193.
2. Anderson, R. A., Martin, C. W., Kung, A. W., Everington, D., Pun, T. C., Tan, K. C., Bancroft, J., Sundaram, K., Moo-Young, A. J. Baird, D. T. (1999) 7-alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 84, 3556 3562.
3. Anderson, R. A., Wallace, A. M., Sattar, N., Kumar, N. Sundaram, K. (2003) Evidence for tissue selectivity of the synthetic androgen 7-alpha-methyl-19-nortestosterone in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 88, 2784 2793.
4. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D. Mitchell, J. B. (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Research 47, 943 946. (Pubitemid 17027906)
5. Castellón, E., Venegas, K., Sáenz, L., Contreras, H. Huidobro, C. (2005) Secretion of prostatic specific antigen, proliferative activity and androgen response in epithelial-stromal co-cultures from human prostatic carcinoma. International Journal of Andrology 28, 39 46.
6. Dixon, S. C., Knopf, K. B. Figg, W. D. (2001) The control of prostate-specific antigen expression and gene regulation by pharmacological agents. Pharmacological Review 53, 73 91.
7. Dorkin, T., Robinson, M., Marsh, C., Bjartell, A., Neal, D. Leung, H. (1999) FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease. Oncogene 18, 2755 2761.
8. von Eckardstein, S., Noe, G., Brache, V., Nieschlag, E., Croxatto, H., Alvarez, F. et al. (2003) International Committee for Contraception Research, The Population Council, a clinical trial of 7-alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. Journal of Clinical Endocrinology and Metabolism 88, 5232 5239.
9. Gleason, D. F. Mellinger, G. T. (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. Journal of Urology 111, 58 64.
10. de Gooyer, M. E., Oppers-Tiemissen, H. M., Leysen, D., Verheul, H. A. Kloosterboer, H. J. (2003) Tibolone is not converted by human aromatase to 7-alpha-methyl-17-alpha-ethynylestradiol (7-alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. Steroids 68, 235 243.
11. Hernandez, J. Thompson, I. M. (2004) Diagnosis and treatment of prostate cancer. Medical Clinics of North America 88, 267 279.
12. Israeli, R. S., Powell, C. T., Fair, W. R. Heston, W. D. (1993) Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Research 53, 227 230.
13. Kumar, N., Didolkar, A. K., Monder, C., Bardin, C. W. Sundaram, K. (1992) The biological activity of 7-alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone. Endocrinology 130, 3677 3683.
14. Kumar, N., Suvisaari, J., Tsong, Y. Y., Aguillaume, C., Bardin, C. W., Lahteenmaki, P. Sundaram, K. (1997) Pharmacokinetics of 7-alphamethyl-19- nortestosterone in men and cynomolgus monkeys. Journal of Andrology 18, 352 358.
15. Kumar, N., Crozat, A., Li, F., Catterall, J. F., Bardin, C. W. Sundaram, K. (1999) 7-alpha-methyl-19-nortestosterone, a synthetic androgen with high potency: structure-activity comparisons with other androgens. The Journal of Steroid Biochemistry and Molecular Biology 71, 213 222.
16. LaMorte, A., Kumar, N., Bardin, C. W. Sundaram, K. (1994) Aromatization of 7-alpha-methyl-19-nortestosterone by human placental microsomes in vitro. The Journal of Steroid Biochemistry and Molecular Biology 48, 297 304.
17. Lee, C., Sutkowski, D. M., Sensibar, J. A., Zelner, D., Kim, I., Amsel, I., Shaw, N., Prins, G. S. Kozlowski, J. M. (1995) Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 136, 796 803.
18. Luke, M. C. Coffey, D. S. (1994) Human androgen receptor binding to the androgen response element of prostate specific antigen. Journal of Andrology 15, 41 51.
19. 4-3-ketosteroid 5-alpha-oxireductase in the nuclear membrane of the rat ventral prostate. Journal of Biological Chemistry 247, 958 967.
20. Negro-Vilar, A. (1999) Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. Journal of Clinical Endocrinology and Metabolism 84, 3459 3462.
21. Noe, G., Suvisaari, J., Martin, C., Moo-Young, A. J., Sundaram, K., Saleh, S. I., Quintero, E., Croxatto, H. B. Lahteenmaki, P. (1999) Gonadotrophin and testosterone suppression by 7-alpha-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men. Human Reproduction 14, 2200 2206.
22. Rittmaster, R. (1997) 5-alpha-reductase inhibitors. Journal of Andrology 18, 582 587.
23. Ryan, C. J. Small, E. J. (2004) Advances in prostate cancer. Current Opinion in Oncology 16, 242 246.
24. Sanchez de la Muela, P., Povo Castilla, J., Bobillo de Lamo, M., Rosales, F. Perez-Piqueras, J. L. (1995) Microparticle immunoenzymatic assay for detection of prostate specific antigen: characterization of the technique and comparative analysis with a monoclonal immunoradiometric assay. Military Medicine 160, 416 419.
25. Shao, T. C., Li, H. L., Kasper, S., Matusik, R., Ittmann, M. Cunningham, G. R. (2006) Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice. Prostate 66, 369 376.
26. Su, Z. Z., Lin, J., Shen, R., Fisher, P. E., Goldstein, N. I. Fisher, P. B. (1996) Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proceeding of the National Academy of Science U S A 93, 7252 7257.
27. Sundaram, K., Kumar, N. Bardin, C. W. (1993) 7-alpha-methyl- nortestosterone (MENT): the optimal androgen for male contraception. Annals of Medicine 25, 199 205.
28. Sundaram, K., Kumar, N. Bardin, C. W. (1994) 7-alpha-methyl-19- nortestosterone: an ideal androgen for replacement therapy. Recent Progress in Hormone Research 49, 373 376.
29. Suvisaari, J., Moo-Young, A., Juhakoski, A., Elomaa, K., Saleh, S. I. Lahteenmaki, P. (1999) Pharmacokinetics of 7-alpha-methyl-19-nortestosterone (MENT) delivery using subdermal implants in healthy men. Contraception 60, 299 303.
30. Tanaka, A., Furuya, A., Yamasaki, M., Hanai, N., Kuriki, K., Kamiakito, T., Kobayashi, Y., Yoshida, H., Koike, M. Fukuyama, M. (1998) High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, inmunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF8. Cancer Research 58, 2053 2056.
31. Tanaka, S., Uedo, H., Mafune, K., Mori, M., Wands, J. Sugimachi, K. (2001) A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma. Digestive Diseases and Sciences 46, 1016 1021.
32. Walton, M., Kumar, N., Baird, D., Ludlow, H. Anderson, R. (2007) 7-alpha-Methyl-19-Nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men. Journal of Andrology 28, 679 688.
33. Wu, J., Payson, R., Lang, J. Chiu, I. (1997) Activation of fibroblast growth factor 8 gene expression in human embryonic carcinoma cells. Journal of Steroid Biochemistry and Molecular Biology 62, 1 10.
34. Yamagata, K., Urakami, K., Ikeda, K., Ji, Y., Adachi, Y., Arai, H., Sasaki, H., Sato, K. Nakashima, K. (2001) High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 12, 57 62.